• Follow The "New" Prostate Cancer InfoLink news blog on TWITTER or FACEBOOK.
  • The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
  • This web site is a service of Prostate Cancer International.

    pcai_cmyk

  • Other PCI web sites

  • The "New" Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services.

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The "New" Prostate Cancer InfoLink is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

    • Perspective Confidentiality Disclosure Reliability Courtesy

The CenterWatch clinical trials listing service

A third resource that may be helpful for patients interested in participating in clinical trials is the CenterWatch clinical trials listing service.

As with Nexcura, CenterWatch is a commercial company and in individual cases it may be supporting the desires of pharmaceutical companies and others to enroll patients into clinical trials, so be a little cautious. However, also like Nexcura, CenterWatch offers a wide range of services that can be very helpful to patients, and particularly to those patients who wish to be informed about clinical trials of new agents for the management of prostate cancer.

If you are interested in finding out about ongoing clinical trials and newly approved drugs for the treatment of prostate cancer, you can link to this Web page and decide whether you are interested in signing up for CenterWatch’s prostate cancer notification services.

Content on this page last reviewed and updated April 6, 2008.